Severe disease state is defined as patients who receive organ failure support in an ICU.
Moderate disease state is defined as:
ANTIBIOTICS | NON-PANDEMIC CAP | PANDEMIC |
---|---|---|
A.1 – Ceftriaxone + Macrolide | ||
A.2 – Moxifloxacin or Levofloxacin | ||
A.3 – Piperacillin‐Tazobactam + Macrolide | ||
A.4 – Amoxicillin‐Clavulanate + Macrolide |
Macrolide Duration | NON-PANDEMIC CAP | PANDEMIC |
---|---|---|
M.1 – Standard course macrolide | ||
M.2 – Extended course macrolide |
Corticosteroid | NON-PANDEMIC CAP / FLU | PANDEMIC |
---|---|---|
C.1 – No corticosteroid | ||
C.3 – Shock‐dependent hydrocortisone | ||
C.5 – Fixed‐course dexamethasone |
Influenza Antiviral | NON-PANDEMIC CAP / FLU | PANDEMIC |
---|---|---|
I.1 – No antiviral for influenza | ||
I.2 – Oseltamivir 5 days | ||
I.3 – Oseltamivir 10 days | ||
I.4 – Baloxavir on days 1 and 4 * | ||
I.5 – 5 days Oseltamivir + Baloxavir on days 1 & 4 * | ||
I.6 – 10 days Oseltamivir + Baloxavir on days 1 & 4 * |
Immunoglobulin | NON-PANDEMIC CAP | PANDEMIC |
---|---|---|
P.1 – No immunoglobulin for COVID‐19 | ||
P.2 – High‐titer convalescent plasma |
Immune Modulation | NON-PANDEMIC CAP / FLU | PANDEMIC |
---|---|---|
N.1 – No immune modulation | ||
N.2 – Tocilizumab | ||
N.3 – Baricitinib |